ALTICE USA INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Altice USA, Inc.
If you hold shares of Altice (NYSE: ATUS), we urge you to contact KSF to discuss your legal rights, without obligation or cost to you, by calling KSF toll-free at 1-833-938-0905, or by e-mailing KSF Managing Partner, Lewis Kahn, ( lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nyse-atus/ to learn more.
About Kahn Swick & Foti, LLC
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, New Jersey, and a representative office in Luxembourg.
TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services
To learn more about KSF, you may visit www.ksfcounsel.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
24 minutes ago
- Globe and Mail
Liminatus Pharma, Inc. Initiates Strategic Review of Blockchain-Integrated Treasury Strategy
LA PALMA, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (NASDAQ: LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted cancer immunotherapies, today announced that it has initiated a strategic review to evaluate the potential inclusion of regulated digital asset strategies as part of its broader treasury management framework. This internal review is part of Liminatus's continued commitment to strong financial stewardship and balance sheet optimization. While its core focus remains firmly on advancing cancer therapies, the Company believes it is prudent to assess innovative financial instruments—including blockchain-based assets—that may enhance treasury efficiency and diversify non-operating capital reserves. 'Liminatus remains fully committed to our mission of developing life-changing cancer therapies,' said Chris Kim, CEO of Liminatus Pharma, Inc. 'At the same time, we believe responsible treasury management is essential to supporting our long-term goals. This review is not a shift in our business focus, but an effort to evaluate modern financial tools—such as regulated digital assets—that may enhance the way we manage non-operating capital.' Liminatus emphasizes that this is an exploratory process only. As of today, the Company has not entered into any agreements regarding the acquisition, custody, or use of digital assets. Any potential future steps would be subject to approval by the Board of Directors and undertaken in full alignment with U.S. Securities and Exchange Commission (SEC) regulations and public company disclosure standards. About Liminatus Pharma, Inc. Liminatus is a preclinical-stage biopharmaceutical company developing immunotherapies for patients with cancer. The Company is advancing a pipeline of novel therapies targeting cancer antigens and tumor-specific immune responses. Liminatus is also committed to responsible innovation in capital strategy to support its long-term scientific and operational objectives. Forward-Looking Statements Certain statements in this press release constitute forward-looking statements. Forward-looking statements include, but are not limited to, statements regarding management's expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words 'anticipate,' 'believe,' 'continue,' 'could,' 'estimate,' 'expect,' 'intends,' 'may,' 'might,' 'plan,' 'possible,' 'potential,' 'predict,' 'project,' 'should,' 'will,' 'would' and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this press release are based on our current expectations and beliefs concerning future developments and their potential effects. Future developments affecting Liminatus may not be those that Liminatus has anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of Liminatus), or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Liminatus undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities laws. In addition, statements that 'we believe' and similar statements reflect beliefs and opinions on the relevant subject. These statements are based upon information available to Liminatus as of the date of this press release, and while Liminatus believes such information forms a reasonable basis for such statements, such information may be limited or incomplete, and such statements should not be read to indicate that Liminatus has conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely upon these statements as predictions of future results. Liminatus's actual future results may be materially different from what it expects. Liminatus qualifies all forward-looking statements by these cautionary statements.
CTV News
an hour ago
- CTV News
Theft of two semi-trucks under investigation in New Tecumseth
A white Freightliner Cascadia semi-truck was reportedly stolen from a business in New Tecumseth on July 16, 2025. Ontario Provincial Police (OPP) is seeking the public's help solving the theft of two brand new semi-trucks from a business in New Tecumseth. Police say the theft of two 2026 white Freightliner Cascadia trucks - one sleeper truck and one day cab truck - happened on July 16 at around 11:30 a.m. at a commercial property on C.W. Leach Road. Investigators obtained surveillance footage, which they say captured four unidentified individuals on the property around 2 a.m. Police say the group arrived in a gunmetal grey four-door sedan with tinted windows and sunroof. Police say no licence plate was obtained, and no further identifying details are available. The investigation is ongoing with police asking anyone with information or surveillance footage of the incident to contact the OPP 1-888-310-1122, quoting report E250940333.
Globe and Mail
an hour ago
- Globe and Mail
Why Lucid Stock Is Skyrocketing Today
Key Points Lucid stock is roaring higher after it was announced that the company's Air vehicles will soon be compatible with Tesla's Supercharger network. Owners of Lucid's Air vehicles will be able to use Tesla's charging network starting July 31. This win comes on the heels of a big robotaxi partnership with Uber. 10 stocks we like better than Lucid Group › The stock of Lucid Group (NASDAQ: LCID) is surging in Tuesday's trading despite moderate bearish momentum for the broader market. The company's share price was up 8.9% as of 12:30 p.m. ET. Meanwhile, the S&P 500 was down 0.1%, and the Nasdaq Composite had fallen 0.7%. The electric vehicle (EV) specialist's valuation is getting a big boost today following news that its Air vehicle models will become compatible with Tesla 's Supercharger network. The news comes on the heels of an announcement that Lucid has formed a robotaxi partnership with Uber, and the EV company's stock is now up roughly 41% over the last month. Lucid stock soars on Tesla Supercharger news All Lucid Air models will become compatible with Tesla's charger network on July 31. Thanks to a new charger adapter that has been approved by Lucid, Air owners will gain access to more than 23,500 charger stations. Tesla has by far the largest network of charging stations, and the new compatibility stands to make vehicle charging significantly more convenient for Air owners. It also has the potential to make Lucid's Air EVs significantly more attractive to prospective buyers. What's next for Lucid? Lucid has been racking up some significant wins recently. As part of their robotaxi partnership, Uber will be purchasing 20,000 or more of its vehicles and outfitting them with autonomous driving technologies from Nuro. With the company having delivered only 10,241 vehicles last year, the deal with Uber looks to be a significant sales catalyst even if purchases will be spread out over a six-year period. Uber has also invested $300 million in the company, and it's possible that Lucid's vehicles being part of its EV fleet will wind up creating broader sales catalysts as more potential buyers become aware of its vehicles. Should you invest $1,000 in Lucid Group right now? Before you buy stock in Lucid Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Lucid Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $665,092!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,050,477!* Now, it's worth noting Stock Advisor's total average return is 1,055% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 21, 2025
